Webinars

PACE/State of FL - This webinar will discuss the advantages of using electrophysiology results to guide the selection of axonal or demyelinating testing for peripheral neuropathy. This approach can help identify specific antibodies associated with the condition, providing a more precise diagnosis, and improving patient outcomes. Accurate diagnosis is crucial for effective treatment, as the therapeutic approach varies based on the underlying cause of peripheral neuropathy.

PACE/State of FL - Updates to pathology and laboratory CPT codes for 2025, including newly added, deleted, and revised codes.

PACE/State of FL - An in-depth look at the efforts to improve the efficiency and effectiveness of the Autopsy Lab through Lean principles.

PACE/State of FL - Substance use disorders and the common laboratory tests and matrices used for controlled substance monitoring.

PACE/State of FL - The latest ASCO guidelines for selection of germline genetic testing panels for cancer patients.

Regulatory compliance and recent policy changes at the federal and state level relevant to hospital laboratory outreach programs.

PACE/State of FL - Metagenomic sequencing for diagnosing central nervous system infection. Content will be shared regarding technical details, clinical applications, and results interpretation, drawing on both current literature and practice guidelines.

PACE/State of FL - An overview of recent operational updates to the Clinical Laboratory Improvement Amendments (CLIA) and administrative process changes in the Centers for Medicare & Medicaid Services (CMS).

PACE/State of FL - The current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can have for affected individuals.

PACE/State of FL - Internal assessments are integral to a laboratory’s quality management system (QMS).

PACE/State of FL - The latest updates in Alzheimer’s disease diagnostic criteria as well as a comprehensive review of the laboratory testing landscape.

PACE/State of FL - The critical role of planning to support innovation and transformation in today's laboratory outreach environment.

PACE/State of FL - A brief history of the FDA’s interest in LDTs and detailing new requirements.